Mark D. Johnson - Concepedia

Author

Mark D. Johnson

The University of Texas Southwestern Medical Center ORCID

Also Known As

Isha Patel, Johnson, Mark D., M D Johnson, M JOHNSON, M Johnson, M. D. JOHNSON, M. D. Johnson, M. Johnson, M.D. Johnson, Madelynn R. Johnson

235

Publications

10.9K

Citations

H-Index

224

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Drexel University Columbia University Allegheny General Hospital Harvard University

About

Mark D. Johnson is an author at The University of Texas Southwestern Medical Center specializing in medicine, pharmacology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	14	16	681
2	Engineering	2	2	162
3	Education	1	1	140
4	Language Studies	1	1	211
5	Management	1	1	147

Mark D. Johnson

Publications

9.4K

Citations

H-Index

Page 1

	Year	Citations
Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis Marc I. Chimowitz, Michael Lynn, Colin P. Derdeyn, New England Journal of Medicine	2011	1.8K
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial Colin P. Derdeyn, Marc I. Chimowitz, Michael Lynn, The Lancet Intracranial Artery StenosisEndovascular TechniqueMedicineRandomised TrialVascular Surgery	2013	845
Early neonatal death in mice homozygous for a null allele of the insulin receptor gene Domenico Accili, John Drago, Eric J. Lee, Nature Genetics Knockout MouseGeneticsDiabetesPhysiologyNull Allele	1996	598
Overproduction of protein kinase C causesdisordered growth control in rat fibroblasts Gerard M. Housey, Mark D. Johnson, W.L. Wendy Hsiao, Cell Rat FibroblastsFibrosisDevelopmental BiologySignal TransductionProtein Kinase C	1988	488
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. Olga V. Volpert, William F. Ward, Mark W. Lingen, Journal of Clinical Investigation Cellular PharmacologyPharmacotherapyTumor BiologyMolecular PharmacologyExperimental Tumors	1996	331
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase Mark D. Johnson, Hyeong‐Reh Choi Kim, Louis Chesler, Journal of Cellular Physiology Endothelial Cell ResponseImmunologyPathologyCellular PhysiologyInflammation	1994	292
Donor leukocyte infusions in acute lymphocytic leukemia RH Collins, Steven C. Goldstein, Sergio Giralt, Bone Marrow Transplantation TransplantationImmunologyHematologyBlood CellDonor Leukocyte Infusions	2000	240
T Cell Development in Mice that Lack the ζ Chain of the T Cell Antigen Receptor Complex Paul E. Love, Elizabeth W. Shores, Mark D. Johnson, Science	1993	220
The Role of the Human Thalamus in Language and Memory: Evidence from Electrophysiological Studies Mark D. Johnson, George A. Ojemann Brain and Cognition Cognitive ScienceMnemonicNeuroanatomyNeurolinguisticsLanguage Neuroscience	2000	211
Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Shoji Yamanaka, Mark D. Johnson, Alexander Grinberg, Proceedings of the National Academy of Sciences	1994	198

Page 1